IP Library › Granted Patent US 12,053,541
Granted Patent B2
US 12,053,541 · App. 17/336,283 · Granted Aug 6, 2024

Compositions for reducing hair loss and/or increasing hair regrowth

Inventor: Houfar Sekhavat (Dieppe, CA)
Assignee: Triple Hair Inc.
A61K8/63A61K8/0204A61K8/046A61K8/361A61K8/37A61K8/4953A61K31/506A61K31/5575A61K31/58A61Q7/00A61K9/0014A61K2800/592
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,053,541
App. No.
17/336,283
Granted
Aug 6, 2024
Kind
B2
Abstract

The invention relates to a composition comprising 2% to 5% minoxidil, 0.01% to 15% finasteride and 0.01% to 15% of a prostaglandin analogue. In one embodiment, the prostaglandin analogue is latanoprost. In a preferred embodiment, the composition comprises 5% minoxidil, 0.1% finasteride and 0.03% latanoprost. The invention also relates to the use of the said composition to reduce hair loss and/or increase regrowth of hair in a human subject.

Claims (21)

1. A composition, consisting of 2% to 5% minoxidil, 0.01% to 15% finasteride, 0.01% to 15% of a prostaglandin analogue, and a mixture of propylene glycol, ethoxy diglycol, and ethanol, wherein the composition reduces hair loss and/or increases hair regrowth upon administration.

2. The composition according to claim 1 , wherein the composition consists of 5% minoxidil, 0.5% finasteride, 0.01% of the prostaglandin analogue, and the mixture of propylene glycol, ethoxy diglycol, and ethanol.

3. The composition according to claim 1 , wherein the composition consists of 5% minoxidil, 0.01% finasteride, 0.03% of the prostaglandin analogue, and the mixture of propylene glycol, ethoxy diglycol, and ethanol.

4. The composition according to claim 1 , wherein the prostaglandin analogue is latanoprost, travoprost, bimatoprost, tafluprost, or unoprostone.

5. The composition according to claim 4 , wherein the prostaglandin analogue is latanoprost.

6. The composition according to claim 1 , wherein the composition reduces hair loss and/or increases hair regrowth in a human subject upon administration.

7. The composition according to claim 6 , wherein the human subject is a male.

8. The composition according to claim 6 , wherein the human subject is a female.

9. The composition according to claim 1 , wherein the composition reduces hair loss and/or increases hair regrowth upon topical administration.

10. The composition according to claim 9 , wherein the composition reduces hair loss and/or increases hair regrowth upon topical administration via a spray.

11. A method of reducing hair loss and/or increasing hair regrowth in a human subject, comprising administering the composition of claim 1 to the human subject.

12. The method according to claim 11 , wherein the human subject is a male.

13. The method according to claim 11 , wherein the human subject is a female.

14. The method according to claim 11 , wherein administering the composition to the human subject comprises administering the composition topically.

15. The method according to claim 14 , wherein administering the composition to the human subject comprises administering the composition topically via a spray.

16. The composition according to claim 1 , wherein the composition consists of 2% to 5% minoxidil, 0.01% to 5% finasteride, 0.01% to 5% of the prostaglandin analogue, and the mixture of propylene glycol, ethoxy diglycol, and ethanol.

17. The composition according to claim 1 , wherein the composition consists of 2% to 5% minoxidil, 0.01% to 0.5% finasteride, 0.01% to 0.5% of the prostaglandin analogue, and the mixture of propylene glycol, ethoxy diglycol, and ethanol.

18. The composition according to claim 17 , wherein the composition consists of 2% to 5% minoxidil, 0.01% to 0.5% finasteride, 0.01% to 0.1% of the prostaglandin analogue, and the mixture of propylene glycol, ethoxy diglycol, and ethanol.

19. The composition according to claim 9 , wherein the composition reduces hair loss and/or increases hair regrowth upon topical administration to a scalp.

20. The method according to claim 14 , wherein administering the composition to the human subject comprises administering the composition topically to a scalp.

21. A composition, consisting of minoxidil, 0.01% to 15% finasteride, a prostaglandin analogue, propylene glycol, ethoxy diglycol, and ethanol, wherein the composition reduces hair loss and/or increases hair regrowth upon administration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2022
From: SEKHAVAT, HOUFAR
To: TRIPLE HAIR INC.
Reel/Frame 059800/0133 →
Continuity (4)
Continuation 15292819 · Oct 13, 2016
Continuation 14917501
Provisional Application 62002397 · May 23, 2014
Related Publication 20210283038A1 · Sep 16, 2021